Olympus Stem Cells Pty Ltd, a business in Sydney Olympic Park, NSW, Australia, are pleased to announce the provision of medical services relating to the use of stem cells for oral and facial neuropathic pain. Full details about the service and what it entails can be obtained at http://www.olympusstemcells.com.au.
The Medical Director of Olympus Stem Cells, Associate Professor Russell Vickers, has published extensively on neuropathic facial pain and stem cells. He is now conducting clinical treatment with stem cells of patients with neuropathic facial pain from idiopathic and acquired conditions. These may be from either dental causes in the head and neck or medical conditions including pain syndromes such as odontalgia, nerve paraesthesiaes from oral surgery or trauma and facial pain syndrome from diseases such as multiple sclerosis.
Associate Professor Vickers believes that it is important for the patient to understand that stem cells cannot treat the underlying neurological disease but only some of the symptoms that may be referable to the disease. That said, through the Olympus Health Group, http://www.olympushealthgroup.com.au, other forms of treatment may also be offered to further improve outcomes and the opportunity to treat the underlying condition. However, this will depend on the cause of the condition and each individual will require a personalized consultation.
Stem cells are extracted from abdominal wall fat following a mini liposuction procedure. The procedure is conducted under local anaesthesia and stem cells extracted following aspiration of 20-40cc's of fat. The cells and stromal vascular fraction are then injected into the nerves in the region of the affected area.
Olympus Stem Cells Pty Ltd are the only company undertaking this ground-breaking treatment in Australia and the Asia-Pacific region. The surgery is day stay only. Associate Professor Vickers' recent research publications pertaining to stem cells and neuropathic facial pain have been published in Human Brain Mapping, Australian Endodontic Journal, Hair Therapy and Transplantation, The Journal of Neuroscience, Journal of Arthritis, Diagnosing Dental and Orofacial Pain, the Journal of the Australian Society of Cosmetic Chemists, Medicine Today, the Open Journal of Dentistry and Oral Medicine, and the Journal of Pain Research. More details can be obtained at http://www.clinicalstemcells.com.
Olympus Stem Cells Pty Ltd are a clinical research and development biotech company engaged in stem cell therapy in Sydney, Australia.
Olympus Stem Cell Centre,
Sydney Olympic Park,
5 Australia Avenue,
Sydney Olympic Park,
NSW, Australia.
April 12, 2018 – Olympus Stem Cells Pty Ltd Australia Demonstrating Superior Stem Cell Numbers and Viability in Treatment for Neuropathy
April 12, 2018 – Stem Cells For Hair Regeneration
April 04, 2018 – Dry Mouth from Sjogren’s Syndrome or Head and Neck Radiation: Olympus Stem Cells Advise Technical Considerations in Surgery
April 03, 2018 – Dry Eyes and Stem Cells: Olympus Stem Cells Advise Technical Considerations in Surgery
April 02, 2018 – Olympus Stem Cells Using Zinc Thymulin, Micro-Fat Grafting and Stem Cells for Baldness
April 02, 2018 – Olympus Stem Cells Using Palmitoylethanolamide (PEA) and Stem Cells for Control of Disabling Facial Neuropathic Pain
March 26, 2018 – Olympus Stem Cells Pty Ltd Highlight Relationship Between Goblet Cells, Neuropathic Pain and Post LASIK Dry Eye Syndrome
March 26, 2018 – Olympus Stem Cells Pty Ltd Highlight Relationship Between Neural Crest Cells and Neuropathic Pain in Empty Nose Syndrome